Allapi's

Allapinin is a drug from the group of antiarrhythmic membrane-stabilizing agents, which is used to treat various heart rhythm disorders.

Producing countries: Russia, Uzbekistan.

Manufacturers: Vilar, GNIISKLS, Dalkhimfarm, Institute of Chemistry of Plant Substances, Moscow Pharmaceutical Factory.

International name: Lappaconitine hydrobromide.

Synonyms: Allarhythmine.

Dosage forms: tablets, substance, injection solution.

Ingredients: lappaconitine hydrobromide.

Indications for use: supraventricular and ventricular arrhythmias, incl. against the background of myocardial infarction, paroxysmal tachycardia.

Contraindications: hypersensitivity, AV block, severe liver and kidney failure.

Side effects: headache, dizziness, tachycardia, allergic reactions.

Special instructions: requires dose adjustment and ECG monitoring if side effects occur, careful use during pregnancy and chronic diseases.

Thus, allapinin is an effective antiarrhythmic drug if the rules for its use and monitoring of the patient’s condition are observed.